We are live on
!
Find out more
LP
Lexington Partners Portfolio holdings
AUM
$134M
1-Year Est. Return
1.93%
This Fund
S&P 500
This Quarter
Est. Return
+10.22%
1 Year Est. Return
-1.93%
3 Year Est. Return
+1.27%
5 Year Est. Return
-12.6%
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$16.5M
(+12%)
Cap. Flow
+$3.8M
Cap. Flow
% of AUM
2.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$2.07M |
| 2 |
QuantumScape Corp
QS
|
+$1.18M |
| 3 |
Sera Prognostics
SERA
|
+$190K |
| 4 |
LegalZoom.com
LZ
|
+$184K |
| 5 |
Coinbase
COIN
|
+$169K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 76.33% |
| 2 | Technology | 20.93% |
| 3 | Healthcare | 1.58% |
| 4 | Consumer Discretionary | 0.85% |
| 5 | Financials | 0.18% |
Similar funds
RA
SWM
SA
SA
GEH
BGI
MMCM
STFP
Lexington Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Lexington Partners held 9 positions worth $152M, up 12% from $136M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Lexington Partners's Q4 2023 filing shows 5 new positions. Its largest new stake was Mirum Pharmaceuticals: 68,519 shares worth $2.02M.
By sector, the portfolio is most concentrated in Consumer Staples at 76% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Lexington Partners's largest Q4 2023 buy was Mirum Pharmaceuticals: 68,519 shares worth $2.02M.
- Lexington Partners's ten largest holdings make up 100% of its $152M portfolio in Q4 2023.
- Lexington Partners opened 5 new positions and closed 0 in Q4 2023.
- Lexington Partners's portfolio value rose 12% quarter-over-quarter to $152M.
Based on Lexington Partners's 13F filing for Q4 2023, filed 12 Feb 2024.